108 related articles for article (PubMed ID: 2504662)
1. Interferon-gamma as an adjuvant in immunocompromised mice.
Heath AW; Devey ME; Brown IN; Richards CE; Playfair JH
Immunology; 1989 Aug; 67(4):520-4. PubMed ID: 2504662
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation.
Holland GP; Holland N; Steward MW
Clin Exp Immunol; 1990 Nov; 82(2):221-6. PubMed ID: 2122931
[TBL] [Abstract][Full Text] [Related]
3. Expression and identification of immunological activities of the HIV-gp120N-human interferon gamma fusion protein.
Feng TT; Zhao G; Yao HP; Wang QP; Wu NP
Anat Rec (Hoboken); 2009 Mar; 292(3):381-6. PubMed ID: 19248157
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
6. Role of interferon-gamma during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins.
Rosa DS; Bastos KR; Bargieri DY; Tzelepis F; Nomizo A; Russo M; Soares IS; Rodrigues MM
Vaccine; 2007 Aug; 25(32):6007-17. PubMed ID: 17629370
[TBL] [Abstract][Full Text] [Related]
7. Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies.
Chruewkamlow N; Mahasongkram K; Pata S; Chaiwarith R; Salee P; Supparatpinyo K; Kasinrerk W
PLoS One; 2016; 11(1):e0145983. PubMed ID: 26727515
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
9. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.
Playfair JH; De Souza JB
Clin Exp Immunol; 1987 Jan; 67(1):5-10. PubMed ID: 3113784
[TBL] [Abstract][Full Text] [Related]
10. B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis.
Olalekan SA; Cao Y; Hamel KM; Finnegan A
Eur J Immunol; 2015 Apr; 45(4):988-98. PubMed ID: 25645456
[TBL] [Abstract][Full Text] [Related]
11. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
12. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
Brando C; Ware LA; Freyberger H; Kathcart A; Barbosa A; Cayphas S; Demoitie MA; Mettens P; Heppner DG; Lanar DE
Infect Immun; 2007 Feb; 75(2):838-45. PubMed ID: 17101665
[TBL] [Abstract][Full Text] [Related]
13. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.
Schijns VE; Haagmans BL; Horzinek MC
J Immunol; 1995 Sep; 155(5):2525-32. PubMed ID: 7650382
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA
Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
16. A T cell-independent mechanism of macrophage activation by interferon-gamma.
Bancroft GJ; Schreiber RD; Bosma GC; Bosma MJ; Unanue ER
J Immunol; 1987 Aug; 139(4):1104-7. PubMed ID: 3112223
[TBL] [Abstract][Full Text] [Related]
17. T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin.
Tomai MA; Johnson AG
J Biol Response Mod; 1989 Dec; 8(6):625-43. PubMed ID: 2513379
[TBL] [Abstract][Full Text] [Related]
18. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
20. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
McCormick AL; Thomas MS; Heath AW
J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
